Médiation de cytotoxicité de cellules mettant en évidence l'expression superficielle de CD44

• 收藏
• 分享

专利权人:

F. Hoffmann-La Roche AG

发明人:

申请号：

EP12174631.7

公开号：

EP2508536A1

申请日:

2007.02.23

申请国别(地区):

EP

年份:

2012

代理人:

摘要：

This invention relates to the diagnosis and treatment of cancerous diseases, particularly to the mediation of cytotoxicity of tumour cells evidencing surface expression of CD44； and most particularly to the use of cancerous disease modifying antibodies (CDMAB), optionally in combination with one or more chemotherapeutic agents, as a means for initiating the cytotoxic response. The invention further relates to binding assays which utilize the CDMAB of the instant invention.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/